J. Safra Sarasin Holding Ag Axsome Therapeutics, Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.79 Trillion
- Q2 2025
A detailed history of J. Safra Sarasin Holding Ag transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 19,658 shares of AXSM stock, worth $2.02 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
19,658
Previous 9,660
103.5%
Holding current value
$2.02 Million
Previous $1.13 Billion
82.14%
% of portfolio
0.04%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding AXSM
# of Institutions
406Shares Held
36.1MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$398 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$338 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$300 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$173 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$100 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.4B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...